Subacute cutaneous lupus erythematosus in the course of rheumatoid arthritis: a relationship with TNF-αantagonists and rituximab therapy?

2013 ◽  
Vol 35 (3) ◽  
pp. 443-446 ◽  
Author(s):  
Anna Lis-Święty ◽  
Ligia Brzezińska-Wcisło ◽  
Małgorzata Widuchowska ◽  
Eugeniusz Kucharz
Keyword(s):  
Rheumatoid Arthritis ◽  
Lupus Erythematosus ◽  
Cutaneous Lupus Erythematosus ◽  
Subacute Cutaneous Lupus Erythematosus ◽  
Cutaneous Lupus

Subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis

2002 ◽  
Vol 31 (6) ◽  
pp. 377-379 ◽  
Author(s):  
Lucia Pantoja ◽  
Marcos Antonio González-López ◽  
Marta Bouso ◽  
Antonio Alija ◽  
Juan Ortiz-Saracho
Keyword(s):  
Rheumatoid Arthritis ◽  
Lupus Erythematosus ◽  
Cutaneous Lupus Erythematosus ◽  
Subacute Cutaneous Lupus Erythematosus ◽  
Cutaneous Lupus

Drug-induced subacute cutaneous lupus erythematosus associated with abatacept

Lupus ◽  
2020 ◽  
pp. 096120332098114
Author(s):  
Eliana Figueredo Zamora ◽  
Jeffrey P Callen ◽  
Courtney R Schadt
Keyword(s):  
Rheumatoid Arthritis ◽  
Lupus Erythematosus ◽  
Time Course ◽  
Cutaneous Lupus Erythematosus ◽  
Clinical Findings ◽  
Subacute Cutaneous Lupus Erythematosus ◽  
Drug Induced ◽  
The Third ◽  
History Of ◽  
Cutaneous Lupus

Numerous drugs have been linked to the induction or exacerbation of systemic cutaneous lupus erythematosus (SCLE). This report presents the third case of the biologic abatacept as an exacerbating medication for SCLE. A 73-year old woman with a remote history of subacute cutaneous lupus and rheumatoid arthritis, well controlled on hydroxychloroquine, presented with worsening annular erythematous, slightly scaly plaques on her forearms and hands. She had been started on abatacept a month prior. She was diagnosed with SCLE exacerbated by abatacept given the clinical findings, time course, and skin biopsy with interface dermatitis. Her skin eruption cleared completely several months later after discontinuing abatacept and switching to tociluzumab, while remaining on hydroxychloroquine. This case highlights the need to consider abatacept as a potential exacerbating medication for SCLE in any patient with a new photodistributed papulosquamous eruption.

scholarly journals Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine

2021 ◽  
Author(s):  
Dennis Niebel ◽  
Veronika Ralser‐Isselstein ◽  
Kristel Jaschke ◽  
Christine Braegelmann ◽  
Thomas Bieber ◽  
...  
Keyword(s):  
Lupus Erythematosus ◽  
Cutaneous Lupus Erythematosus ◽  
Subacute Cutaneous Lupus Erythematosus ◽  
Cutaneous Lupus
Sign in / Sign up

Export Citation Format

Share Document